Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise

Stopped Company decision taken in light of demands by certain national health authorities

Conditions

• Obesity
• Diabetes Mellitus Type 2

Interventions

• DRUG: Rimonabant
• DRUG: placebo (for Rimonabant)
• OTHER: Diet and exercise

Sponsor

Sanofi